Production and regulation of interleukin-11 by breast cancer cells

Cancer Letters

Volumn 127, Issue 1-2, 1998, Pages 29-35

  Lacroix, Marc ^a   Siwek, Brigitte ^a   Marie, Pierre J ^b   Body, Jean Jacques ^a  

^a Lab d'Invest Clin d'Oncol E   (Belgium)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Bone metastases; Breast cancer cells; Interleukin 11; Interleukin 6; TGF

Indexed keywords

FORSKOLIN; INTERLEUKIN 11; INTERLEUKIN 6; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL DIVISION; CYCLOHEXIMIDE; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; INTERLEUKIN-11; INTERLEUKIN-6; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032523874     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00542-9     Document Type: Article

References (30)

1. Du X., Williams D.A. Interleukin-11: review of molecular, cell biology, and clinical use. Blood. 89:1997;3897-3908.
2. Hughes F.J., Howells G.L. Interleukin-11 inhibits bone formation in vitro. Calcif. Tissue Int. 53:1993;362-364.
3. Girasole G., Passeri G., Jilka R.L., Manolagas S.C. Interleukin-11: a new cytokine critical for osteoclast development. J. Clin. Invest. 93:1994;1516-1524.
4. Body J.J., Coleman R.E., Piccart M. Use of bisphosphonates in cancer patients. Cancer. Treat. Rev. 22:1996;265-287.
5. Taube T., Elomaa I., Blomqvist C., Beneton M.N.C., Kanis J.A. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone. 15:1994;161-166.
6. Manolagas S.C., Jilka R.L. Bone marrow, cytokines, and bone remodeling. N. Engl. J. Med. 332:1995;305-311.
7. Siwek B., Demulder A., Lacroix M., Body J.J. Establishment and characterization of three new breast cancer cell lines. J. Bone Miner. Res. 11(Suppl. 1):1996;S480.
8. Lacroix M., Body J.J. Regulation of c-fos and c-jun expression by calcitonin in human breast cancer cells. Calcif. Tissue Int. 60:1997;513-519.
9. Marie P.J., Lomri A., Sabbagh A., Basle M. Culture and behaviour of osteoblastic cells isolated from normal trabecular bone surfaces. In Vitro Dev. Biol. 25:1989;373-380.
10. Sommers C.L., Byers S.W., Thompson E.W., Torri J.A., Gelmann E.P. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res. Treat. 31:1994;325-335.
11. Elias J.A., Zheng T., Whiting N.L., Trow T.K., Merrill W.W., Zitnik R., Ray P., Alderman E.M. Il-1 and transforming growth factor-β regulation of fibroblast-derived Il-11. J. Immunol. 152:1994;2421-2429.
12. Elias J.A., Tang W., Horowitz M.C. Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology. 136:1995;489-498.
13. Danforth D.N., Sgagias M.K. Interleukin-1alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res. 53:1993;1538-1545.
14. Faggioli L., Costanzo C., Merola M., Bianchini E., Furia A., Carsana A., Palmieri M. Nuclear factor B (NF-κB), nuclear factor interleukin-6 (NFIL-6 or C/EBPβ) and nuclear factor interleukin-6β (NFIL6-β or C/EBPδ) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Eur. J. Biochem. 239:1996;624-631.
15. Thompson E.W., Paik S., Brunner N., Sommers C.L., Zugmaier G., Clarke R., Shima T.B., Torri J., Donohue S., Lippman M.E., Martin G.R., Dickson R.B. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol. 150:1992;534-544.
16. Hackett A.J., Smith H.S., Springer E.L., Owens R.B., Nelson-Rees W.A., Riggs J.L., Gardner M.B. Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. J. Natl. Cancer Inst. 58:1977;1795-1807.
17. Cailleau R., Young R., Olivé M., Reeves W.J. Jr. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53:1974;661-674.
18. Dickson R.B., Bates S.E., McManaway M.E., Lippman M.E. Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res. 46:1986;1707-1713.
19. 2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br. J. Cancer. 72:1995;1412-1419.
20. Guise T.A., Yin J.J., Taylor S.D., Kumagai Y., Dallas M., Boyce B.F., Yoneda T., Mundy G.R. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J. Clin. Invest. 98:1996;1544-1549.
21. Nakshatri H., Bhat-Nakshatri P., Martin D.A., Goulet R.J. Jr., Sledge G.W. Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:1997;3629-3639.
22. Bitko V., Velazquez A., Yang L., Yang Y.-C., Barik S. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-κB and is inhibited by sodium salicylate and aspirin. Virology. 232:1997;369-378.
23. Douglas A.M., Goss G.A., Sutherland R.L., Hilton D.J., Berndt M.C., Nicola N.A., Begley C.G. Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene. 14:1997;661-669.
24. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:1997;797-819.
25. Yoneda T., Sasaki A., Mundy R. Osteolytic bone metastasis in breast cancer. Breast Cancer Res. Treat. 32:1994;73-84.
26. Clohisy D.R., Palkert D., Ramnaraine M.L.R., Pekurovsky I., Oursler M.J. Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis. J. Orthop. Res. 14:1996;396-402.
27. Orr F.W., Kostenuik P., Sanchez-Sweatman O.H., Singh G. Mechanisms involved in the metastasis of cancer to bone. Breast Cancer Res. Treat. 25:1993;151-163.
28. J.M. Wozney, V. Rosen, in: G.R. Mundy, T.J. Martin (Eds.), Growth factors in bone, Physiology and Pharmacology of Bone, Springer-Verlag, New York, 1993, pp. 725-748.
29. Morinaga Y., Fujita N., Ohishi K., Tsuruo T. Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-β and tumor cell factors. Int. J. Cancer. 71:1997;422-428.
30. Basolo F., Conaldi P.G., Fiore L., Calvo S., Toniolo A. Normal breast epithelial cells produce interleukins 6 and 8 together with tumor-necrosis factor: defective IL6 expression in mammary carcinoma. Int. J. Cancer. 55:1993;926-930.